Get started
Author

Adolfo Aita

Sudden Cardiac Death in Hypertensive Patients
2019 · Paolo Verdecchia, Fabio Angeli, et al. · Hypertension · 69
Left Ventricular Hypertrophy and Obesity: Only a Matter of Fat?
2014 · Giuseppe Murdolo, Fabio Angeli, et al. · High Blood Pressure & Cardiovascular Prevention · 52
Why switch from warfarin to NOACs?
2016 · Paolo Verdecchia, Fabio Angeli, et al. · Internal and Emergency Medicine · 50
European and US guidelines for arterial hypertension: similarities and differences
2019 · Fabio Angeli, Gianpaolo Reboldi, et al. · European Journal of Internal Medicine · 40
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation
2017 · Maria Cristina Vedovati, Paolo Verdecchia, et al. · International Journal of Cardiology · 33
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach
2014 · Paolo Verdecchia, Fabio Angeli, et al. · Expert Opinion on Drug Safety · 25
Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension
2017 · Paolo Verdecchia, Fabio Angeli, et al. · Journal of the American Heart Association · 18
Managing hypertension in 2018: which guideline to follow?
2019 · Fabio Angeli, Gianpaolo Reboldi, et al. · Heart Asia · 17
PDF
Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study
2018 · Paolo Verdecchia, Antonio D’Onofrio, et al. · Journal of Cardiovascular Medicine · 17
Detrimental Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: New Insights from Umbria Atrial Fibrillation Registry
2019 · Fabio Angeli, Gianpaolo Reboldi, et al. · Medicina · 6
PDF
Electrocardiography for diagnosis of left ventricular hypertrophy in hypertensive patients with atrial fibrillation
2019 · Fabio Angeli, Paolo Verdecchia, et al. · International Journal of Cardiology Hypertension · 6
PDF
Safety of Dabigatran in an Elderly Population: Single Center Experience in Italy
2014 · Paolo Verdecchia, Gabriella Molini, et al. · Current Drug Safety · 5
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study
2018 · Paolo Verdecchia, Maria Cristina Vedovati, et al. · Expert Opinion on Drug Safety · 4
The revolution of the anti-diabetic drugs in cardiology
2020 · Paolo Verdecchia, Fabio Angeli, et al. · European Heart Journal Supplements · 3
PDF
Gathering evidence on the prognostic role of central blood pressure in hypertension
2018 · Fabio Angeli, Gianpaolo Reboldi, et al. · Hypertension Research · 3
Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies
2015 · Fabio Angeli, Gianpaolo Reboldi, et al. · Mini-Reviews in Medicinal Chemistry · 3
Hypertensive Heart Disease
2018 · Fabio Angeli, Gianpaolo Reboldi, et al. · Updates in hypertension and cardiovascular protection · 2
Prognostic Impact of Different Definitions of White-Coat Hypertension
2025 · Paolo Verdecchia, Stefano Coiro, et al. · American Journal of Hypertension · 1
PDF
A18644 Echocardiography in Low-Risk Hypertensive Patients. When is it needed?
2018 · Paolo Verdecchia, Adolfo Aita, et al. · Journal of Hypertension
Quali novità nella gestione dell’ipertensione arteriosa dopo le recenti linee guida europee e nordamericane?
2018 · Paolo Verdecchia, Fabio Angeli, et al. · Giornale italiano di cardiologia
What is new in the management of arterial hypertension after the recent European and North American guidelines
2018 · Paolo Verdecchia, Fabio Angeli, et al.
Pressione arteriosa: più bassa è, meglio è? Forse sì
2016 · Paolo Verdecchia, Fabio Angeli, et al. · Giornale italiano di cardiologia
Ischemic cardiopathy and hypertension: which role for the internist?
2015 · Fabio Angeli, Gianpaolo Reboldi, et al. · IrInSubria (University of Insubria)
Works count: 24
Citation count: 354
H-index: 9
I10-index: 9
Year
Topic
Type